Global Thrombosis Drugs Market Outlook to 2023; Driven by the Growing Awareness of Cardiac Care - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 18, 2018--The “Global Thrombosis Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The thrombosis drugs market will register a CAGR of more than 9% by 2023.
Sedentary lifestyle is resulting in an increase in the number of thrombosis cases. The increase in sedentary lifestyle is leading to the rise in the prevalence of obesity across the world, thus increasing the risk of thrombosis.
Growing awareness of cardiac care
The increasing awareness of cardiac care is leading to the early diagnosis of various cardiac diseases. Various awareness camps have been organized by the governments and non-government organizations across the world to increase the awareness of heart health among the population.
Strong side-effects of anticoagulants
Anticoagulants or blood thinners are medications that are developed to dissolve blood clots in the body. Blood thinners have high efficacy. However, the side effects associated with the use of these drugs to treat thrombosis are high.
With the presence of a considerable number of companies, this market appears to be concentrated and with all companies constantly focusing improving their market positions, the competitive environment among the players is quite intense. The market is witnessing the entry of various generic drug manufacturing companies that are coming up with generic versions of the drugs.
Key PlayersBoehringer Ingelheim Bristol-Myers Squibb DAIICHI SANKYO Johnson & Johnson Sanof i
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY INDICATIONMarket segmentation by indication Comparison by indication Pulmonary embolism - Market size and forecast 2018-2023 DVT - Market size and forecast 2018-2023 Market opportunity by indication
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPEGeographic segmentation Geographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPEOverview Landscape disruption Competitive scenario
PART 13: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors Boehringer Ingelheim Bristol-Myers Squibb DAIICHI SANKYO Johnson & Johnson Sanof i
For more information about this report visit https://www.researchandmarkets.com/research/6ltwg9/global_thrombosis?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005644/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/18/2018 11:55 AM/DISC: 12/18/2018 11:55 AM